Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Withdrawn 1Recruiting 1Completed 1

Sponsor Class

INDIV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Neoplasms 1Barrett Esophagus 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Proflavine × Clear all
NCT02018367 2021-01-14

Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma

Anandasabapathy, Sharmila, M.D.

Phase 2 Unknown
100 enrolled
Gastrointestinal

Barrett Esophagus

NCT02029937 2021-01-14

High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia

Anandasabapathy, Sharmila, M.D.

Phase 2 Unknown
1,300 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡